MOUNTAINSIDE Trademark

Trademark Overview

On Monday, July 27, 2020, a trademark application was filed for MOUNTAINSIDE with the United States Patent and Trademark Office. The USPTO has given the MOUNTAINSIDE trademark a serial number of 90075111. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by Astellas Pharma Global Development, Inc.. The MOUNTAINSIDE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; and scientific study and research in the field of pharmaceuticals for treatment of mitochondrial diseases and disorders
mountainside

General Information

Serial Number90075111
Word MarkMOUNTAINSIDE
Filing DateMonday, July 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the fields of pharmaceuticals and clinical trials; and scientific study and research in the field of pharmaceuticals for treatment of mitochondrial diseases and disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 24, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Global Development, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062
Party NameAstellas Pharma Global Development, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062

Trademark Events

Event DateEvent Description
Thursday, July 30, 2020NEW APPLICATION ENTERED
Monday, August 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 13, 2020ASSIGNED TO EXAMINER
Tuesday, November 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 12, 2021SOU TEAS EXTENSION RECEIVED
Monday, July 12, 2021SOU EXTENSION 1 FILED
Monday, July 12, 2021SOU EXTENSION 1 GRANTED
Friday, January 21, 2022SOU EXTENSION 2 FILED
Friday, January 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 21, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 25, 2022SOU EXTENSION 3 FILED
Monday, July 25, 2022SOU EXTENSION 3 GRANTED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2023SOU EXTENSION 4 FILED
Monday, January 23, 2023SOU EXTENSION 4 GRANTED
Saturday, August 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 5 FILED
Friday, August 11, 2023SOU EXTENSION 5 GRANTED
Friday, August 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 1, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

mountainside research pharmaceuticals scientific treatment field diseases disorders study mitochondrial clinical